Challenges to the effective delivery of health care to people with chronic hepatitis B in Australia

Article

<< Previous

Next >>

Contents Vol 9(2)

doi:10.1071/SH10137

Publishing on sexual health from the widest perspective

	Search




	Advanced Search



	Journal Home

	About the Journal

	Editorial Committee

	Contacts



	Content

	Online Early

	Current Issue

	Just Accepted

	All Issues

	Online Early

	Special Issues

	Sample Issue



	For Authors

	General Information

	Instructions to Authors

	Submit Article

	Open Access



	For Referees

	Referee Guidelines

	Review Article

	Annual Referee Index



	For Advertisers



	For Subscribers

	Subscription Prices

	Customer Service

	Print Publication Dates

e-Alerts

Subscribe to our Email Alert or

feeds for the latest journal papers.

Connect with us

Interview with Kit Fairley

Hear Kit Fairley speak about what is sexual health.

Challenges to the effective delivery of health care to people with chronic hepatitis B in Australia

Jack Wallace ^A ^C , Stephen McNally ^A , Jacqui Richmond ^B , Behzad Hajarizadeh ^A and Marian Pitts ^A

^A Australian Research Centre in Sex, Health and Society, La Trobe University, 215 Franklin Street, Melbourne, Vic. 3000, Australia.
^B St. Vincent’s Hospital, 41 Victoria Parade, Fitzroy, Vic. 3065, Australia.
^C Corresponding author. Email: j.wallace@latrobe.edu.au

Sexual Health 9(2) 131-137 http://dx.doi.org/10.1071/SH10137
Submitted: 25 October 2010 Accepted: 2 May 2011 Published: 24 August 2011





	Full Text



	PDF (127 KB)



	Export Citation

Print

Abstract

Background: The complexity of the hepatitis B natural history and its prevalence in specific populations in Australia challenges the capacity of the health system to deliver health care effectively to affected people. This study explores the challenges in delivering health care to people with chronic hepatitis B (CHB) in Australia. Methods: We conducted a grounded theory based qualitative study in which data were gathered from 70 in-depth interviews with government program officers, clinicians and health and community workers across Australia, and four focus group discussions with 40 health and community workers from the communities most at risk of CHB. Results: A systematic approach to screening populations at risk, including people born in countries with intermediate or high prevalence of CHB; consensus on clinical guidelines; development of a shared care framework for CHB involving general practitioners; and effective communication between patients and health professionals were identified as essential. Workforce development, particularly for primary health care professionals, and developing the knowledge and capacity of health professionals to communicate effectively with people with HBV were described as other major factors in reducing the barriers to CHB treatment in Australia. Conclusion: To improve the clinical management of people with CHB in Australia, the health system needs to encourage the screening of people at risk, improve access to clinical services, and the knowledge and communication skills of primary health care and community health service providers. This study supported developing a shared care model and related infrastructures including training programs, referral pathways and clinical guidelines.

Additional keywords: access, health system, public health, qualitative research, screening.

References

[1] World Health Organization (WHO). Disease and injury regional estimates for 2004. Geneva: WHO; 2004. Available online at: http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html [verified August 2010].

[2] National Health and Medical Research Council (NHMRC). The Australian immunisation handbook. 9th edn. Canberra: NHMRC; 2008.

[3] Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006; 368: 938–45.
| CrossRef | PubMed |

[4] Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatology 2003; 39: 64–9.
| CrossRef |

[5] Hahné S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy. J Clin Virol 2004; 29: 211–20.
| CrossRef | PubMed |

[6] Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology 2007; 46: 1034–40.
| CrossRef | PubMed |

[7] Nguyen MH, Keeffe EB. Chronic hepatitis B and hepatitis C in Asian Americans. Rev Gastroenterol Disord 2003; 3: 125–34.
| PubMed |

[8] Nguyen VTT, Razali K, Amin J, Law MG, Dore GJ. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J Gastroenterol Hepatol 2008; 23: 922–9.
| CrossRef |

[9] Nightingale S, Stormon MO, Day AS, Webber MT, Ward KA, O’Loughlin EV. Chronic hepatitis B and C infection in children in New South Wales. Med J Aust 2009; 190: 670–3.
| PubMed |

[10] Guirgis M, Zekry A, Yan K, Bu YM, Lee A. Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes. J Gastroenterol Hepatol 2009; 24: 998–1001.
| CrossRef | PubMed |

[11] Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. Thousand Oaks: Sage Publications Ltd; 2006.

[12] Butler JR, Korda RJ, Watson KJ, Watson AR. The impact of chronic hepatitis B in Australia: projecting mortality, morbidity and economic impact. Canberra: Australian Centre for Economic Research on Health; 2009.

[13] Wilson J, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.

[14] Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Morb Mortal Wkly Report 2008; 57: 1–20.

[15] Hann H-WL, Hann RS, Maddrey WC, Hepatitis B. Virus infection in 6,130 unvaccinated Korean-Americans surveyed between 1988 and 1990. Am J Gastroenterol 2007; 102: 767–72.
| CrossRef |

[16] Wallace J, McNally S, Richmond J, Hajarizadeh B, Pitts M. Managing chronic hepatitis B: a qualitative study exploring the perspective of people living with chronic hepatitis B in Australia. BMC Public Health 2011; 4: 45.
| CrossRef |

[17] Lok ASF, McMahon BJ. AASLD practice guidelines; chronic hepatitis B: update 2009. Hepatology 2009; 50: 661–2.
| CrossRef |

[18] European Association for the Study of the Liver EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227–42.
| CrossRef | PubMed |

[19] Digestive Health Foundation. Australian and New Zealand chronic hepatitis B (CHB) recommendations, 2nd edition 2009/10. Melbourne: Digestive Health Foundation, Gastroenterological Society of Australia; 2008. Available online at: http://www.gesa.org.au/professional/guidelines/ChronicHepatitisB.cfm [verified July 2010].

[20] Caruana SR, Kelly HA, De Silva SL, Chea L, Nuon S, Saykao P, et al Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong region. Aust N Z J Public Health 2005; 29: 64–8.
| CrossRef | PubMed |

[21] Tran TT. Understanding cultural barriers in hepatitis B virus infection. Cleve Clin J Med 2009; 76: S10–3.
| CrossRef | PubMed |

[22] Tan NC, Cheah SL. What barriers do primary care physicians face in the management of patients with chronic hepatitis B infection in primary care? Singapore Med J 2005; 46: 333–9.
| CAS | PubMed |

Legal & Privacy | Contact Us | Help